An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Condition: Hypercholesterolemia Interventions: Drug: Alirocumab SAR236553 (REGN727); Drug: Rosuvastatin; Drug: Ezetimibe; Drug: Cholestyramine; Drug: Nicotinic acid; Drug: Fenofibrate; Drug: Omega-3 fatty acids; Drug: Atorvastatin; Drug: Simvastatin; Drug: Fluvastatin; Drug: Pravastatin; Drug: Lovastatin Sponsors: Sanofi; Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | Children | Crestor | Fenofibrate | Fluvastatin | Lipitor | Lovastatin | Pravastatin | Rosuvastatin | Simvastatin | Statin Therapy | Study | Tricor | Vytorin | Zetia | Zivast | Zocor